然而还是有些专家担心,为这么早期的症状定名并进行筛检,最终可能会把一大群人列入某个分类里,导致其中一些人担心在阿尔茨海默氏症尚无有效治疗手段的时候会患上这种病。
“There’s the potential benefit of early diagnosis, identifying people more likely to decline,” said Dr. Kenneth Langa, a professor of internal medicine at the University of Michigan. But “the flip side is overdiagnosis, labeling someone and getting people in the clinical cascade, where you start doing the test and people start doing more brain imaging and being at the doctor’s more and getting more concerned.
“早期诊断、辨认出那些更可能患病的人或许有好处,”芝加哥大学(University of Michigan)内科教授肯尼斯‧兰加(Kenneth Langa)博士表示。不过“从另一面来看,这也是过度诊断、给人贴标签、让人陷入没完没了的临床程序。当你开始做检测,民众就要开始做更多脑部显影扫描、更常看医生,也会产生更多担心”。
“If it becomes a routine practice, that’s a huge amount of dollars.”
“要是这成了例行工作,得花上很一大笔钱。”
Dr. Langa, who has written about M.C.I., cited the experience with that designation. Many people given an M.C.I. diagnosis do not develop full-blown dementia even a decade later, and as many as 20 percent have later been deemed cognitively normal, he said.
【34个性格行为问题帮助诊断早期失智症】相关文章:
★ 爱能化解一切辛劳
最新
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15